The Liver Meeting 2019-When All Else Fails: Evolving Indications for SLKT

When All Else Fails: Evolving Indications for SLKT

Video Transcription

Video Summary

Dr. Juan Carlos Caicedo discussed the evolving indications for simultaneous liver-kidney transplant (SLK) in the United States. He highlighted the complexities in determining when SLK is necessary, particularly emphasizing the importance of patient criteria and outcomes. Dr. Caicedo presented data indicating that patients post-liver transplant on dialysis have better survival rates with a kidney transplant. He examined the challenges in decision-making, such as distinguishing reversible kidney injury from irreversible conditions. Additionally, he explored the issue of kidney rejection post-SLK and the use of more potent induction therapy. Dr. Caicedo addressed the safety net option for patients who do not qualify for SLK but develop kidney dysfunction post-liver transplant. He emphasized the need for further research on biomarkers, post-transplant immunosuppression, and kidney after liver transplant outcomes to optimize patient care.

Asset Caption

Presenter: Josh Levitsky

Keywords

simultaneous liver-kidney transplant

patient criteria

kidney rejection

induction therapy

post-transplant outcomes